Your browser doesn't support javascript.
loading
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis.
Zhou, Guiling; Verweij, Stefan; Bijlsma, Maarten J; de Vos, Stijn; Oude Rengerink, Katrien; Pasmooij, Anna Maria Gerdina; van Baarle, Debbie; Niesters, Hubert G M; Mol, Peter; Vonk, Judith M; Hak, Eelko.
Affiliation
  • Zhou G; Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands g.zhou@rug.nl.
  • Verweij S; Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
  • Bijlsma MJ; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
  • de Vos S; Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
  • Oude Rengerink K; Unit of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
  • Pasmooij AMG; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
  • van Baarle D; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
  • Niesters HGM; Virology and Immunology Research Group, Department of Medical Microbiology and Infection Prevention, University Medical Centre, Groningen, The Netherlands.
  • Mol P; Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, Groningen, The Netherlands.
  • Vonk JM; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
  • Hak E; Department of Clinical Pharmacy and Pharmacology, University Medical Centre, Groningen, The Netherlands.
BMJ Open Respir Res ; 10(1)2023 08.
Article in En | MEDLINE | ID: mdl-37640510

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: BMJ Open Respir Res Year: 2023 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: BMJ Open Respir Res Year: 2023 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom